蓝细菌领域动态监测平台

监测主题：: report on , Allergy Immunotherapy , changing market , resourceful guide , adoption rates

摘要 |

HTML | 网页快照 | | 0次

摘要 |

HTML | 网页快照 | | 1次

摘要 |

HTML | 网页快照 | | 2次

4 2020-05-22 Go-ahead for first peanut allergy drug 自然生物技术 News & Comment

监测对象：: Palforzia , DBV Technologies , Viaskin Peanut , The US Food and Drug Administration , 916 Accesses 5 Altmetric Metrics details Download PDF

监测主题：: daily dose , United States , milk allergy , transdermal peanut tolerance patch , peanut exposure

摘要 |

HTML | 网页快照 | | 19次

5 2020-05-22 Go-ahead for first peanut allergy drug 自然生物技术自然生物技术-新闻评论

监测对象：: Palforzia , DBV Technologies , The US Food and Drug Administration , Viaskin Peanut , Paris

监测主题：: daily dose , United States , milk allergy , transdermal peanut tolerance patch , peanut exposure

摘要 |

HTML | 网页快照 | | 20次

6 2020-04-11 Go-ahead for first peanut allergy drug 自然生物技术自然生物技术-新闻评论

监测对象：: Palforzia , DBV Technologies , The US Food and Drug Administration , Viaskin Peanut , Paris

监测主题：: daily dose , United States , milk allergy , transdermal peanut tolerance patch , peanut exposure

摘要 |

HTML | 网页快照 | | 10次

7 2020-04-11 Go-ahead for first peanut allergy drug 自然生物技术 News & Comment

监测对象：: Palforzia , DBV Technologies , The US Food and Drug Administration , Viaskin Peanut , Paris

监测主题：: daily dose , United States , milk allergy , transdermal peanut tolerance patch , peanut exposure

摘要 |

HTML | 网页快照 | | 15次

[1 页/ 7 条记录]